Weekly infusion trial aims to ease deadly fluid buildup in liver patients
NCT ID NCT05867602
Summary
This study is testing if giving a higher, weekly dose of a protein called albumin can better control a dangerous fluid buildup in the abdomen (ascites) for people with advanced liver cirrhosis. It will compare the standard care to standard care plus weekly albumin infusions in 100 participants. The main goals are to see if the high-dose treatment reduces the need for fluid-draining procedures, prevents other serious complications, and improves one-year survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASCITES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor St' Lukes Medical center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.